Crossmark

Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-020-04633-3

Published Online: 2020-09-16

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Caballero Bermejo, Antonio F.

Ruiz-Antorán, Belén https://orcid.org/0000-0002-2020-9077
Fernández Cruz, Ana

Diago Sempere, Elena

Callejas Díaz, Alejandro

Múñez Rubio, Elena

Avendaño-Solá, Cristina

Ramos Martínez, Antonio

Sancho López, Aránzazu

,
Funding

Funding for this research was provided by:

Sanofi Genzyme
License Information

Text and Data Mining valid from 2020-09-16

Version of Record valid from 2020-09-16
More Information

Article History

Received: 20 July 2020

Accepted: 26 July 2020

First Online: 16 September 2020

Ethics approval and consent to participate

: The Research Ethics Committee (REC) at Hospital Universitario Puerta de Hierro Majadahonda approved protocol SARTRE on May 22, 2020 (Reference: 77/20). The research team certifies that this trial has received ethical approval from the appropriate ethical committee. Informed consent to participate will be obtained from all participants or from their legally authorized representatives.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below